Zurcher Kantonalbank (Zurich Cantonalbank) Immunic, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 21, 2022	BUY	$9.54 - $14.26 $28,915 - $43,222	3,031 New	3,031 $34,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

40.2M

Call Options Held

1.14M

Put Options Held

130K

Bvf Inc San Francisco, CA

8.9M
Shares

$6.86 Million
0.43% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

7.29M
Shares

$5.62 Million
0.66% of portfolio
Avidity Partners Management LP Dallas, TX

4.45M
Shares

$3.43 Million
1.09% of portfolio
Vanguard Group Inc Valley Forge, PA

3.93M
Shares

$3.03 Million
0.0% of portfolio
Gratus Capital LLC

2.11M
Shares

$1.62 Million
0.1% of portfolio

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $23.5M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account